Rasamoelisolo
Michele Rasamoelisolo, Montreal CA
Patent application number | Description | Published |
---|---|---|
20110071082 | LONG LASTING ANTI-ANGIOGENIC PEPTIDES - Modified anti-angiogenic peptides are disclosed. The modified peptides are capable of forming a peptidase stabilized anti-angiogenic peptide. The modified anti-angiogenic peptides, particularly modified kringle 5 peptides are capable of forming a conjugate with a blood protein. Conjugates are prepared from anti-angiogenic peptides, particularly kringle 5 peptides, by combining the peptide with a reactive functional group with a blood protein. The conjugates may be formed in vivo or ex vivo. The conjugates are administered to patients to provide an anti-angiogenic effect. | 03-24-2011 |
Michele Rasamoelisolo, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20090068676 | Diagnostic methods for congestive heart failure - The invention provides an assay for the quantification of circulating glycophorin in biological fluid samples. The circulating glycophorin measured by this assay is a truncated glycophorin diagnostic for congestive heart failure (CHF). | 03-12-2009 |
Michele Rasamoelisolo, Winnipeg Manitoba CA
Patent application number | Description | Published |
---|---|---|
20110183436 | DIAGNOSTIC METHODS FOR CONGESTIVE HEART FAILURE - The invention provides an assay for the quantification of circulating glycophorin in biological fluid samples. The circulating glycophorin measured by this assay is a truncated glycophorin diagnostic for congestive heart failure (CHF). | 07-28-2011 |